Dergi makalesi Açık Erişim

The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma

Hu, Xiaozhou; Baytak, Esra; Li, Jinnan; Akman, Burcu; Okay, Kaan; Hu, Genfu; Scuto, Anna; Zhang, Wenyan; Kucuk, Can


JSON

{
  "conceptrecid": "43896", 
  "created": "2021-03-15T21:14:11.564060+00:00", 
  "doi": "10.1016/j.leukres.2017.01.001", 
  "files": [
    {
      "bucket": "1de95819-cc28-4acc-ac2f-b6c4cc8f6e75", 
      "checksum": "md5:fac5332ebe39e791580056a585a754c6", 
      "key": "bib-cdc083f8-f00f-4092-aa93-e52a98c9ee23.txt", 
      "links": {
        "self": "https://aperta.ulakbim.gov.tr/api/files/1de95819-cc28-4acc-ac2f-b6c4cc8f6e75/bib-cdc083f8-f00f-4092-aa93-e52a98c9ee23.txt"
      }, 
      "size": 259, 
      "type": "txt"
    }
  ], 
  "id": 43897, 
  "links": {
    "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1016/j.leukres.2017.01.001.svg", 
    "bucket": "https://aperta.ulakbim.gov.tr/api/files/1de95819-cc28-4acc-ac2f-b6c4cc8f6e75", 
    "doi": "https://doi.org/10.1016/j.leukres.2017.01.001", 
    "html": "https://aperta.ulakbim.gov.tr/record/43897", 
    "latest": "https://aperta.ulakbim.gov.tr/api/records/43897", 
    "latest_html": "https://aperta.ulakbim.gov.tr/record/43897"
  }, 
  "metadata": {
    "access_right": "open", 
    "access_right_category": "success", 
    "communities": [
      {
        "id": "tubitak-destekli-proje-yayinlari"
      }
    ], 
    "creators": [
      {
        "affiliation": "Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey", 
        "name": "Hu, Xiaozhou"
      }, 
      {
        "name": "Baytak, Esra"
      }, 
      {
        "affiliation": "Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Guangxi, Peoples R China", 
        "name": "Li, Jinnan"
      }, 
      {
        "affiliation": "Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey", 
        "name": "Akman, Burcu"
      }, 
      {
        "affiliation": "Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey", 
        "name": "Okay, Kaan"
      }, 
      {
        "name": "Hu, Genfu"
      }, 
      {
        "affiliation": "City Hope Med Ctr, Dept Pathol, Duarte, CA USA", 
        "name": "Scuto, Anna"
      }, 
      {
        "affiliation": "Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Guangxi, Peoples R China", 
        "name": "Zhang, Wenyan"
      }, 
      {
        "name": "Kucuk, Can"
      }
    ], 
    "description": "Follicular lymphoma (FL) is a common type of indolent lymphoma that occasionally transforms to more aggressive B-cell lymphomas. These transformed follicular lymphomas (tFL) are often associated with chemoresistance whose mechanisms are currently unknown. REL, a proto-oncogene located on frequently amplified 2p16.1-p15 locus, promotes tumorigenesis in many cancer types through deregulation of the NF-KB pathway; however, its role in FL pathobiology or chemoresistance has not been addressed. Here, we evaluated REL gene copy number by q-PCR on FFPE FL tumor samples, and observed REL amplification in 30.4% of FL cases that was associated with weak elevation of transcript levels. PCR-Sanger analysis did not show any somatic mutation in FL tumors. In support of a marginal oncogenic role, a REL-transduced FL cell line was positively selected under limiting serum conditions. Interestingly, reanalysis of previously reported gene expression profiles revealed significant enrichment of DNA damage-induced repair and cell cycle arrest pathways in tFL tumors with high REL expression compared to those with low REL expression consistent with the critical role of c-REL in genotoxicity-induced NF-KB signaling, which was reported to lead to drug resistance. In addition to DNA damage repair genes such as ATM and BRCA1, anti-apoptotic BCL2 was significantly elevated in REL-high FL and tFL tumors. Altogether these data suggest that other genes located in amplified 2p16.1-p15 locus may have more oncogenic role in FL etiology; however, high REL expression may be useful as a predictive biomarker of response to immunochemotherapy, and inhibition of c-REL may potentially sensitize resistant FL or tFL cells to chemotherapy. (C) 2017 Elsevier Ltd. All rights reserved.", 
    "doi": "10.1016/j.leukres.2017.01.001", 
    "has_grant": false, 
    "journal": {
      "pages": "30-38", 
      "title": "LEUKEMIA RESEARCH", 
      "volume": "54"
    }, 
    "license": {
      "id": "cc-by"
    }, 
    "publication_date": "2017-01-01", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "43897"
          }, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "43896"
          }
        }
      ]
    }, 
    "resource_type": {
      "subtype": "article", 
      "title": "Dergi makalesi", 
      "type": "publication"
    }, 
    "title": "The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma"
  }, 
  "owners": [
    1
  ], 
  "revision": 1, 
  "stats": {
    "downloads": 6.0, 
    "unique_downloads": 6.0, 
    "unique_views": 22.0, 
    "version_downloads": 6.0, 
    "version_unique_downloads": 6.0, 
    "version_unique_views": 22.0, 
    "version_views": 22.0, 
    "version_volume": 1554.0, 
    "views": 22.0, 
    "volume": 1554.0
  }, 
  "updated": "2021-03-15T21:14:11.613166+00:00"
}
22
6
görüntülenme
indirilme
Görüntülenme 22
İndirme 6
Veri hacmi 1.6 kB
Tekil görüntülenme 22
Tekil indirme 6

Alıntı yap